{{Rsnum
|rsid=7744
|Gene=MYD88
|Chromosome=3
|position=38142530
|Orientation=plus
|GMAF=0.1694
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=MYD88
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 72.6 | 25.7 | 1.8
| HCB | 38.0 | 45.3 | 16.8
| JPT | 51.3 | 43.4 | 5.3
| YRI | 97.3 | 2.7 | 0.0
| ASW | 84.2 | 15.8 | 0.0
| CHB | 38.0 | 45.3 | 16.8
| CHD | 45.0 | 44.0 | 11.0
| GIH | 84.2 | 15.8 | 0.0
| LWK | 95.5 | 4.5 | 0.0
| MEX | 58.6 | 34.5 | 6.9
| MKK | 91.0 | 8.3 | 0.6
| TSI | 80.4 | 18.6 | 1.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=21525878
|Title=A single nucleotide polymorphism in the 3'-untranslated region of MyD88 gene is associated with Buerger disease but not with Takayasu arteritis in Japanese
}}

{{PMID Auto
|PMID=18776126
|Title=Toll-like receptor 9 affects severity of IgA nephropathy.
|OA=1
}}

{{PMID Auto
|PMID=20448286
|Title=Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NF{kappa}B signalling pathways.
}}

{{PMID Auto
|PMID=20463618
|Title=Role of polymorphic variants as genetic modulators of infection in neonatal sepsis.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | NatGeo2}}